KORU Medical Systems, Inc. (KRMD)
About KORU Medical Systems, Inc.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $41.1M
- Net income
- -$2.6M
- Total assets
- $28.2M
- Market cap
- $180.5M
- Gross margin
- 62.3%
- Operating margin
- -7.2%
- Net margin
- -6.4%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $41.1M
- Cost of revenue
- $15.5M
- Gross profit
- $25.6M
- Operating expenses
- $28.6M
- Operating income
- -$3.0M
- Income tax
- $21.9K
- Net income
- -$2.6M
- EPS (basic)
- $-0.06
- EPS (diluted)
- $-0.06
Balance sheet
- Total assets
- $28.2M
- Current assets
- $20.0M
- Total liabilities
- $11.2M
- Current liabilities
- $8.2M
- Shareholders’ equity
- $17.0M
Cash flow
- Operating cash flow
- $462.4K
- Investing cash flow
- -$949.8K
- Financing cash flow
- -$221.3K
- Net cash flow
- -$708.7K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $180.5M
- EPS (diluted)
- $-0.06
- Shares outstanding
- 47.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 1, 1996
KORU Medical Systems, Inc. (KRMD) Stock Price
- Reported a net loss of $2.6M in FY2025.
- Revenue grew 75% from FY2021 to FY2025.
- Gross margin of 62.3%, net margin -6.4%.
- Trading 41% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review KORU Medical Systems, Inc..
Write a review
News about KORU Medical Systems, Inc.
News & sentiment via Polygon.io
KORU Medical Systems, Inc.: frequently asked questions
Is KORU Medical Systems, Inc. an American company?
KORU Medical Systems, Inc. is a US-based company headquartered in Mahwah, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is KORU Medical Systems, Inc. headquartered?
KORU Medical Systems, Inc. is headquartered in Mahwah, New Jersey, United States.
Is KORU Medical Systems, Inc. publicly traded?
Yes — KORU Medical Systems, Inc. is a publicly traded company. Its stock trades under the ticker symbol KRMD on the NASDAQ.
What does KORU Medical Systems, Inc. do?
KORU Medical Systems, Inc. is an American Medical Devices company in the Health & Beauty sector.
